Avatrombopag is a small-molecule thrombopoietin receptor agonist that increases platelet counts. It is a pharmaceutical raw material used in the manufacturing of oral formulations for patients with thrombocytopenia associated with chronic liver disease.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 570406-98-3
Avatrombopag maleate
thrombopoietin receptor agonist
Ethyl 1-(3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylate
research compound
LUSUTROMBOPAG
thrombopoietin receptor agonist
Eltrombopag Amide
thrombopoietin receptor agonist
Eltrombopag olamine
thrombopoietin receptor agonist
Suprane
inhalation anesthetic
6-Ketoestradiol
Active pharmaceutical ingredient
4-[(4-methyl-4-oxidopiperazin-4-ium-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
active pharmaceutical ingredient
1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]-2-pyridinyl]piperidine-4-carboxylic acid
OFZJKCQENFPZBH-UHFFFAOYSA-N
C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl